Bio-Gen Extracts Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 06-10-2024
- Paid Up Capital ₹ 1.08 Cr
as on 06-10-2024
- Company Age 24 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.25 Cr
as on 06-10-2024
- Satisfied Charges ₹ 45.14 Cr
as on 06-10-2024
- Revenue 10.45%
(FY 2023)
- Profit -1.83%
(FY 2023)
- Ebitda 2.36%
(FY 2023)
- Net Worth 8.39%
(FY 2023)
- Total Assets 18.44%
(FY 2023)
About Bio-Gen Extracts
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.08 Cr.
The company currently has active open charges totaling ₹19.25 Cr. The company has closed loans amounting to ₹45.14 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jai Chandra, Piyush Mohta, and Saif Mehkri serve as directors at the Company.
- CIN/LLPIN
U74999KA2000PTC027440
- Company No.
027440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bio-Gen Extracts Private Limited offer?
Bio-Gen Extracts Private Limited offers a wide range of products and services, including Root and Vegetable Extracts, Ginger Extract, Food Enzymes, Bromelain, Herbal Extracts, Lycopene Extract, Antioxidants, Astaxanthin Powder, Plant Extracts, Bacopa Monnieri Extract.
Who are the key members and board of directors at Bio-Gen Extracts?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jai Chandra  | Director | 11-Jul-2000 | Current |
| Piyush Mohta | Director | 11-Jul-2000 | Current |
| Saif Mehkri | Director | 11-Jul-2000 | Current |
Financial Performance and Corporate Structure Insights of Bio-Gen Extracts.
Bio-Gen Extracts Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.45% increase. The company also saw a slight decrease in profitability, with a 1.83% decrease in profit. The company's net worth moved up by a moderate rise of 8.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio-Gen Extracts?
In 2023, Bio-Gen Extracts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Jun 2017 | ₹19.25 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 19 Nov 2014 | ₹4.00 Cr | Satisfied |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 04 Feb 2013 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Bio-Gen Extracts?
Bio-Gen Extracts has a workforce of 125 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio-Gen Extracts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-Gen Extracts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
